加州太平洋生物科學公司 PACB 深 滬
等待開盤 03-26 09:30:00 美东时间
1.39
0.000
0.00%
華盛通- 最 高1.45
- 今 開1.41
- 成交量 294.20万股
- 最 低 1.365
- 昨 收 1.39
- 總市值 4.20亿
- 52周最高 2.73
- 市盈率 靜 --
- 換手率 0.97%
- 52周最低 0.8511
- 委 比 -9.81%
- 總股本 3.02亿
- 歷史最高 53.69
- 量 比 0.63
- 振 幅 6.12%
- 歷史最低 0.8511
- 每 手 1
- 風險率 0.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多新浪财经ESG：Pacific Biosciences of Californi MSCI（明晟）ESG评级调降至B
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:27
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
As part of a broader review of life science and diagnostic tools stocks, Barclays upgraded contract research organizations IQVIA Holdings (IQV) and Medpace Holdings (MEDP) on Friday, noting that conce...
03-07 02:44
Barclays Downgrades Pacific Biosciences to Underweight, Lowers Price Target to $1.5
Barclays analyst Luke Sergott downgrades Pacific Biosciences (NASDAQ:PACB) from Equal-Weight to Underweight and lowers the price target from $2 to $1.5.
03-06 22:04
Pacific Biosciences of California Inc. Director Christopher Gibson Files Initial Statement of Beneficial Ownership (Form 3)
Pacific Biosciences of California Inc. Director Christopher Gibson Files Initial Statement of Beneficial Ownership (Form 3) Pacific Biosciences of California Inc. filed an initial statement of beneficial ownership (Form 3) naming Christopher Gibson as a director. The full filing can be accessed thro
03-05 21:40
BRIEF-Pacbio Announces The Appointment Of Chris Gibson To The Board Of Directors
BRIEF-Pacbio Announces The Appointment Of Chris Gibson To The Board Of Directors March 5 (Reuters) - Pacific Biosciences of California Inc PACB.O : PACBIO ANNOUNCES THE APPOINTMENT OF CHRIS GIBSON TO THE BOARD OF DIRECTORS Source text: ID:nGNXpJW9P Further company coverage: PACB.O (( Reuters.Briefs@
03-05 21:33
PacBio names Chris Gibson to board of directors
PacBio names Chris Gibson to board of directors Pacific Biosciences of California Inc. has appointed Christopher Gibson, Ph.D., to its Board of Directors. Gibson is a co-founder and the chairman of Recursion, an AI-driven drug discovery company, and brings experience in integrating large-scale biolo
03-05 21:30
Pacific Biosciences Of California Inc Files For Mixed Shelf; Size Not Disclosed
-SEC Filing
02-26 05:47
PacBio and DNAstack Launch Global Federated HiFi Whole Genome Dataset for Rare Disease Research
PacBio and DNAstack Launch Global Federated HiFi Whole Genome Dataset for Rare Disease Research Pacific Biosciences (PacBio) has partnered with DNAstack to power what the companies describe as the first global federated dataset of HiFi whole genome sequencing data for rare disease research. Through
02-24 22:05
Pacific Biosciences shares are trading lower. The company reported Q4 financial results.
Pacific Biosciences shares are trading lower. The company reported Q4 financial...
02-14 01:57
